Basal Cell Carcinoma Treatment Market by Treatment Type (Surgery, Drugs, and Others) and by End-user (Hospitals, Specialty Clinics, and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Global basal cell carcinoma market expected to generate revenue of around USD 9789.6 million by end of 2024, growing at a CAGR of around 8.9% between 2018 and 2024. Basal cell carcinoma market is mainly driven by the increased prevalence of various skin diseases such as melanoma and others.

28-Aug-2018 | Number of pages: 110 | Report Code: ZMR-3297 | Report Format : | Status : Published

Analysis

Basal cell carcinoma is a type of nonmelanocytic cancer that arises from basal cells present in the lower epidermis. It does not spread to other parts of the body but in rare cases, it can metastasize to other body parts and it is generally caused by the exposure to ultraviolet rays. Immunosuppressant drugs are further expected to increase the probability of basal cell carcinoma as the immune system is suppressed by these drugs. Basal cell carcinoma can be life-threatening in rare conditions and white people are considered more vulnerable to basal cell carcinoma. The symptom for basal cell carcinoma includes waxy papules with a central depression and bleeding can also be observed from those papules. There are various treatment options available for the basal cell carcinoma such as surgery, drugs, and others such as radiation therapy and it may take some time to get completely cured.

The major factors driving the growth of basal cell carcinoma treatment market over the forecast period are an increase in various types of skin disorders coupled with melanoma and others. Increased prevalence of cutaneous malignancies is further expected to drive the growth of basal cell carcinoma treatment market. As per the American Cancer Society 2018 report, an estimated 91,270 adults (55,150 men and 36,120 women) in the United States were diagnosed with melanoma of the skin. Melanoma is the fifth most common cancer among men and the sixth most common cancer in women. Australia is expected to have a number of cases for basal cell carcinoma as compared to other countries. Furthermore, increase in geriatric population, increased prevalence, and favorable reimbursement policies are further expected to support the growth of basal cell carcinoma treatment market.

Global Basal Cell Carcinoma Treatment Market

Basal cell carcinoma treatment market is segmented on the basis of treatment type, end-user, and region. Treatment type segment is further classified into surgery, drugs, and others. Surgery segment is expected to grow rapidly over the forecast period. Based on the end user, the market is segmented into hospitals, specialty clinics, and others. Hospitals and specialty clinics are expected to grow significantly in the near future.

Basal cell carcinoma treatment is regionally segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to contribute to the major market share which is expected to be closely followed by Europe over the forecast period. The major contribution of these regions is due to the advanced medical and healthcare facilities and infrastructure. The Asia Pacific is expected to grow moderately over the forecast period. Latin America and the Middle East and Africa are expected to develop at a considerable rate within the forecast period.

Some of the key players of basal cell carcinoma treatment market include Merck & Co. Inc., Valeant Pharmaceuticals International Inc., F. Hoffmann-La Roche Ltd., Mylan N.V., Sun Pharmaceuticals Ltd., Allergan, Inc., Perrigo Company plc, and Strides Arcolab Ltd., amongst others.


Related Reports

Hyperhidrosis Treatment Market: By Treatment Type (Botulinum Toxin A, Non-Surgical Microwave Energy Destruction of Sweat Glands, Iontophoresis, Topical Treatments, Surgical Treatments, and Others), By Type (Axillary Hyperhidrosis, Plantar Hyperhidrosis, Palmar Hyperhidrosis, and Others), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Jan-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5214 | Report Format:

The report includes Revenue forecast analysis of the hyperhidrosis treatment market on a global as well as regional level. It also offers historic data of 2016 and 2017 and provides a valuation of the industry surge during 2019-2025 in terms of USD Billion. Our study includes competitive strategi...Read More

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Macular Degeneration Treatment Market: by Drug Class (Anti-VEGFs and Other Drugs); by Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)); by Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Nov-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5117 | Report Format:

The report covers forecast and analysis for the macular degeneration treatment market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the macular degenerat...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.